MA28467B1 - Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Info

Publication number
MA28467B1
MA28467B1 MA29320A MA29320A MA28467B1 MA 28467 B1 MA28467 B1 MA 28467B1 MA 29320 A MA29320 A MA 29320A MA 29320 A MA29320 A MA 29320A MA 28467 B1 MA28467 B1 MA 28467B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
heterocyclic compound
compositions containing
antioxidant agent
novel association
Prior art date
Application number
MA29320A
Other languages
English (en)
Inventor
Louis Casteilla
Luc Penicaud
Pascal Berthelot
Catherine Dacquet
Daniel-Henri Caignard
Original Assignee
Servier Lab
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Centre Nat Rech Scient filed Critical Servier Lab
Publication of MA28467B1 publication Critical patent/MA28467B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

NOUVELLE ASSOCIATION ENTRE UN COMPOSE HETEROCYCLIQUE ET UN AGENT ANTIOXYDANT ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT Association contenant un dérivé favorisant les métabolismes lipidique et glucidique de l'organisme et un agent antioxydant. Médicaments.
MA29320A 2004-03-31 2006-09-14 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent MA28467B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403359A FR2868313B1 (fr) 2004-03-31 2004-03-31 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
MA28467B1 true MA28467B1 (fr) 2007-03-01

Family

ID=34945535

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29320A MA28467B1 (fr) 2004-03-31 2006-09-14 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Country Status (18)

Country Link
US (1) US20070167502A1 (fr)
EP (1) EP1729767A1 (fr)
JP (1) JP2007530643A (fr)
KR (1) KR100842567B1 (fr)
CN (1) CN100536842C (fr)
AR (1) AR048355A1 (fr)
AU (1) AU2005232420B8 (fr)
BR (1) BRPI0509389A (fr)
CA (1) CA2563104A1 (fr)
EA (1) EA012966B1 (fr)
FR (1) FR2868313B1 (fr)
GE (1) GEP20094637B (fr)
MA (1) MA28467B1 (fr)
MY (1) MY142039A (fr)
NO (1) NO20064858L (fr)
UA (1) UA86801C2 (fr)
WO (1) WO2005099694A1 (fr)
ZA (1) ZA200607798B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894965B1 (fr) * 2005-12-20 2008-01-25 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2898125B1 (fr) * 2006-03-06 2008-06-13 Servier Lab Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
EP1024804A4 (fr) * 1997-05-01 2001-03-21 Bristol Myers Squibb Co Combinaisons therapeutiques d'inhibiteur de mtp et de vitamine liposoluble destinees a reduire les taux de lipides seriques
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
FR2804431A1 (fr) * 2000-02-02 2001-08-03 Adir Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10044805A1 (de) * 2000-09-11 2002-04-04 Martin Klingenberg Verwendung von Coenzym Q zur Regulierung der Funktion der Entkopplerproteine
WO2002034259A1 (fr) * 2000-10-26 2002-05-02 Fournier Laboratories Ireland Limited Combinaison de fenofibrate et de coenzyme q10 permettant de traiter un dysfonctionnement endothelial
JP2003116487A (ja) * 2001-10-15 2003-04-22 Beverly Corporation:Kk 痩身用食品
FR2845601B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU2005232420B8 (en) 2009-06-11
WO2005099694A8 (fr) 2006-11-09
BRPI0509389A (pt) 2007-09-18
JP2007530643A (ja) 2007-11-01
KR20060133073A (ko) 2006-12-22
CA2563104A1 (fr) 2005-10-27
FR2868313B1 (fr) 2008-08-15
AU2005232420A1 (en) 2005-10-27
EP1729767A1 (fr) 2006-12-13
GEP20094637B (en) 2009-03-10
KR100842567B1 (ko) 2008-07-01
EA012966B1 (ru) 2010-02-26
HK1099689A1 (zh) 2008-10-24
CN100536842C (zh) 2009-09-09
AU2005232420B2 (en) 2009-02-19
NO20064858L (no) 2006-10-25
UA86801C2 (ru) 2009-05-25
FR2868313A1 (fr) 2005-10-07
CN1938024A (zh) 2007-03-28
AR048355A1 (es) 2006-04-19
EA200601632A1 (ru) 2007-04-27
US20070167502A1 (en) 2007-07-19
WO2005099694A1 (fr) 2005-10-27
ZA200607798B (en) 2008-05-28
MY142039A (en) 2010-08-30

Similar Documents

Publication Publication Date Title
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
DK1140198T3 (da) Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ES2124852T3 (es) Formulaciones de rapamicina para administracion oral.
MA28467B1 (fr) Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
MA27402A1 (fr) Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
WO2003061572A8 (fr) Formulations anti-inflammatoires
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
MXPA04007875A (es) Composiciones depiladoras.
FR2817257B1 (fr) Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
BRPI0407596A (pt) formulações orais semi-sólidas para liberação imediata compreendendo um agente anticáncer hidrofóbico, um glicerìdio poliglicolisado e veìculo hidrofìlico
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
FR2845601B1 (fr) Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
AR031846A1 (es) Combinacion de sustancias activas, medicamentos y formulaciones que la contienen, y uso de la misma para la preparacion de un medicamento para el tratamiento del dolor
AU2003202550A1 (en) Pharmaceutical formulations with modified release
MA27114A1 (fr) Nouvelle association d&#39;un antithrombotique et d&#39;aspirine
SE0102636D0 (sv) Kondomförpackning